New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
10:00 EDTQIWI, MTX, ZPIN, SRPT, PTCT, ENPH, WPG, QSII, NEP, CSG, TSE, AXYS, ATNM, ABYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abengoa Yield (ABY) initiated with an Equal Weight at Morgan Stanley... Actinium Pharmaceuticals (ATNM) initiated with a Buy at Canaccord... Axys Technologies (AXYS) initiated with a Buy at Dougherty... Chambers Street Properties (CSG) initiated with a Neutral at SunTrust... Enphase Energy (ENPH) initiated with a Buy at Dougherty... Minerals Technologies (MTX) initiated with an Outperform at Wedbush... NextEra Energy Partners (NEP) initiated with a Buy at BofA/Merrill... PTC Therapeutics (PTCT) initiated with a Buy at BofA/Merrill... QIWI (QIWI) initiated with a Positive at Susquehanna... Quality Systems (QSII) initiated with a Buy at Topeka... Sarepta (SRPT) initiated with a Neutral at BofA/Merrill... Trinseo S.A. (TSE) initiated with a Buy at BofA/Merrill... Washington Prime Group (WPG) initiated with a Neutral at SunTrust... Zhaopin (ZPIN) initiated with a Buy at UBS.
News For ABY;ATNM;AXYS;CSG;ENPH;MTX;NEP;PTCT;QIWI;QSII;SRPT;TSE;WPG;ZPIN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
08:08 EDTPTCTPTC Therapeutics Translarna granted orphan designation in U.S., EU
Subscribe for More Information
December 18, 2014
15:13 EDTABYAbengoa awarded 950 GWh per year in 15 year Chilean supply tender
Subscribe for More Information
06:35 EDTPTCTPTC Therapeutics initiated with a Buy at Citigroup
Subscribe for More Information
December 17, 2014
05:36 EDTQSIIQuality Systems names Zachary Sherburne Global Chief Information Officer
Quality Systems announced the appointment of Zachary Sherburne to the post of senior vice president and Global Chief Information Officer. Prior to joining Quality Systems, Sherburne was Chief Information Officer and vice president of information services in the hardware and home improvement division of Spectrum Brands.
December 16, 2014
16:26 EDTQIWIOn The Fly: Closing Wrap
Stocks on Wall Street opened in negative territory following another tumble in the price of oil and Russian central bank intervention on the ruble. The continued decline in crude and the sudden rate hike in Russia led to an early sell-off, though the market soon pared its losses and the Dow eventually built a 200 point gain before noon. The swing of 300 points for the Dow was indicative of the day’s volatility. The market moved across the flat line again and in the end the sellers regained control and pushed the market to another loss. ECONOMIC EVENTS: In the U.S., housing starts fell 1.6% to a 1.028M rate in November, which was worse than the expected 3.1% increase. Building permits dropped 5.2% to a 1.035M rate in the month, which was also worse than the consensus forecast for a 2.5% drop. Markit's flash PMI for the U.S. dropped to 53.7 in December from 54.8 in November, which is an 11 month low and worse than the 55.2 reading that was forecast. In China, HSBC and Markit's preliminary manufacturing PMI fell to 49.5 in December from a final 50.0 reading in November. In Europe, Markit's composite PMI for the euro zone rose to 51.7, which was up from November's final reading of 51.1 and just above analyst forecasts for a reading of 51.5. Additionally, Russia's central bank raised its key interest rate to 17% from 10.5% in an effort to limit substantially increased ruble depreciation risks and inflation risks. COMPANY NEWS: Spain's Repsol (REPYY) announced plans to buy Talisman Energy (TLM) for $8 per share in cash, which was at the high end of the range reported recently by Financial Times. Talisman shares trading in New York surged $2.46, or 48.05%, to $7.58 following the deal announcement, while Repsol slipped 18c, or 0.93%, to $19.26. MAJOR MOVERS: The top nine gainers on the S&P 500 were all oil and gas exploration or services companies. After those came CVS Health (CVS), which gained $2.44, or 2.72%, to $92.31 after the company announced in conjunction with its analyst day meeting that it added $10B to its share repurchase plan, boosted its dividend 27%, affirmed its outlook for this fiscal year and pointed to growing earnings in its next fiscal year. Among the noteworthy losers was heavy truck maker Navistar (NAV), which fell $5.95, or 16.98%, to $29.10 after reporting losses for its just completed quarter. Also lower were shares of Russian companies listed in the U.S., including QIWI (QIWI), which dropped $2.81, or 13.06%, to $18.70 and Mobile TeleSystems (MBT), which slid 75c, or 10.84%, to $6.17. INDEXES: The Dow fell 111.97, or 0.65%, to 17,068.87, the Nasdaq dropped 57.32, or 1.24%, to 4,547.83, and the S&P 500 declined 16.89, or 0.85%, to 1,972.74.
12:26 EDTQIWIOn The Fly: Midday Wrap
Subscribe for More Information
December 12, 2014
12:02 EDTPTCTPTC Therapeutics Translarna granted orphan drug designation
Subscribe for More Information
December 11, 2014
12:58 EDTABYAbengoa Yield price target raised to $45 from $42 at Morgan Stanley
Morgan Stanley said its views Abengoa Yield's (ABY) update on its asset acquisition plans and governance changes as positive and increased its price target on the stock to $45 from $42. The firm maintains its Overweight rating on Abengoa Yield.
12:55 EDTABYAbengoa Yield begins talks for third acquisition from Abengoa
Subscribe for More Information
08:15 EDTABYAbengoa Yield files to sell 9.2M ordinary shares for shareholder
Subscribe for More Information
December 10, 2014
07:40 EDTTSEBofA/Merrill to hold a conference
2014 U.S. Basic Materials Conference is being held in Boston on December 10-11.
07:29 EDTTSETrinseo management to meet with Deutsche Bank
Subscribe for More Information
December 9, 2014
12:15 EDTPTCTPTC Therapeutics mentioned positively by dealReporter
Subscribe for More Information
09:24 EDTENPHEnphase Energy should be bought after pullback, says Roth Capital
Subscribe for More Information
07:14 EDTATNMActinium Pharmaceuticals SAB endorses Iomab-B Phase 3 clinical trials
Subscribe for More Information
December 8, 2014
10:00 EDTQIWIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:42 EDTQIWIQIWI downgraded to Neutral from Buy at UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use